The accumulation of fat in the liver under many diverse experimental conditions has frequently been used as an index of fat mobilization from adipose tissue (1) (2) (3) (4) (5) (6) . In recent years, it has become clear that the free fatty acids (FFA) of the plasma represent a major transport form for mobilization of lipid from adipose tissue (7, 8) and methods are now generally available for measurement of this important plasma lipid component (7, 9, 10) . Therefore, it is now possible to examine more directlv this inferred relationship between mobilization of fat and the development of fatty liver. The present experiments were designed to determine whether increasing the rate of mobilization of fatty acids from the periphery in normal animals might lead to development of fatty liver. Epinephrine causes an immediate and marked increase in the rate of release of FFA from adipose tissue in vitro (11) and in vivo (12) , and norepinephrine acts similarly (13, 14) . Because the FFA response to norepinephrine is smoother and more sustained than the response to epinephrine (13) , the former has been used in most of these experiments.
METHODS AND EXPERIMENTAL PROCEDURE
Experiments were performed on male mongrel dogs weighing 8 to 15 kg, maintained for 1 to 3 weeks on a diet of canned meat 1 which was offered each morning for a period of 4 hours. Following a 24-hour fast, the animals, anesthetized with sodium pentothal (thiopental), received via the femoral vein an 8-hour infusion of norepinephrine 2 in saline (1 to 2 Ag per kg per minute) while the control animals received only saline. The infusion was delivered by a Bowman pump at a constant rate of 1 ml per minute. Before starting the infusion, liver biopsies (1 to 2 g) were obtained through an abdominal incision which was closed before the infusion was begun. 1 Red Heart Dog Food, John Morrel and Co. 2 Parke, Davis and Co.
Portal vein infusions were administered by way of a small polyethylene catheter introduced into a splenic vein and threaded up to the portal vein at the time of laparotomy. At the end of the 8-hour infusion, a second liver biopsy was obtained through the same incision which was reopened for this purpose. In one experiment, serial liver biopsies were obtained at 0, 2, 4 and 8 hours during the course of a norepinephrine infusion. Serial blood samples were taken throughout each infusion. All blood samples were drawn from the femoral vein into dry syringes, transferred to heparin-containing tubes, promptly chilled, and kept at 40 C until analytical procedures were started. Plasma FFA were determined by the method of Dole (9) . All biopsies were analyzed for total cholesterol (15) , phospholipids (16) , and total lipids (17) , and examined histologically for fat using an Oil Red 0 stain. Triglycerides were calculated by the Bragdon method (17) . The portions of the liver biopsies used for lipid analysis were homogenized in acetone-ethanol (1: 1, vol/vol) and centrifuged. One aliquot of the supernatant was taken for cholesterol determination and the remainder was taken to dryness under nitrogen. The residue was taken up in chloroformmethanol (2: 1), water was added to separate the two phases, and aliquots of the chloroform phase were taken for determination of phospholipids and total lipids. Blood glucose was measured calorimetrically by the SomogyiNelson method (18) .
Liver lipids were fractionated into subclasses using a silicic acid column according to Borgstrom (19) . The neutral lipids as a group were eluted with chloroform and the phospholipids with methanol. The lipids in the chloroform eluate were then applied to silicic acid-treated paper on which the cholesterol esters and glycerides were separated by using 99 per cent iso-octane, 1 per cent acetic anhydride as solvent (20) . The lipid spots on the paper were identified by staining with a spray of 0.04 per cent Rhodamine B in methanol. Then the spots were cut out and eluted with chloroform-methanol (2: 1), which was then evaporated to dryness in small glass tubes. One ml of methanol containing 2 per cent HSO (vol/vol) was then added to each tube, the tubes were sealed, and the mixtures were heated at 650 C overnight. One ml of water was then added to each tube and the methyl esters were extracted into petroleum ether. The petroleum ether extracts were concentrated and aliquots were analyzed by gas-liquid chromatography. The column used was a U-shaped glass column, 4 
RESULTS
Comparative effects of epinephrine and norepinephrine on plasma FFA and glucose levels during an 8-hour infusion. Figure 1 represents the changes in plasma FFA and glucose levels during norepinephrine infusion (top half), and at a later date, and in the same dog, during epinephrine infusion (bottom half). The FFA response to norepinephrine was sustained at high levels throughout the 8-hour infusion, dropping precipitously when the infusion was terminated. The FFA response to epinephrine was prompt and marked but the maximal levels reached were not as high as those seen with norepinephrine. Despite continued infusion of epinephrine at the same rate, the FFA level fell to values not far above the control level but then rose again later in the experiment. These changes in FFA level appeared to bear a reciprocal relation to changes in blood glucose levels. Norepinephrine has insignificant glycogenolytic properties compared with epinephrine (22) , and no rise in blood glucose is seen with the former. Norepinephrine was therefore chosen for the following experiments in which sustained FFA levels were desired. Effect of an 8-hour infusion of norepinephrine on liver lipids. In Figure 2 the effect of an 8-hour infusion of norepinephrine on liver triglyceride concentration is illustrated. There was a progressive rise in liver triglyceride content throughout the infusion from an initial level of 4 to 5 mg per g liver to an 8-hour concentration of 33 mg per g. Associated with the increase in triglycerides was a marked elevation of the plasma concentration of FFA which continued until the infusion was terminated. The microscopic appearance of the liver is shown in Figure 3 , in which a progressive rise in stainable fat is seen with a striking fatty infiltration by 8 hours.
Seven experiments were carried out in which the changes in plasma FFA concentration and the changes in liver lipid concentrations were measured over the course of an 8-hour infusion of norepinephrine. The FFA responses are shown in Figure 4 (E-K), along with the curves for FFA concentration in four control animals (A-D) receiving intravenous saline only. The corresponding changes in liver lipids are tabulated in Table I . All experimental animals (E-K) had a marked and sustained elevation of plasma FFA for the duration of the infusion, which was associated with increases in liver triglyceride as great as tenfold over the 8-hour period (mean increase, 773 per cent). The Figure 6 are included in Table I epinephrine, and of liver lipids and plasma FFA after infusion. In experiment F (see Table I and Figure 4) , the fatty acid compositions of the liver lipid fractions, plasma FFA and adipose tissue were determined and are shown in Figure 7 . While the triglyceride content of the liver increased from 3 to 39 mg per g liver, the decrease in linoleic acid at the end of 8 These experiments demonstrate that a sustained elevation of plasma FFA concentration, induced in this case by constant intravenous infusion of norepinephrine, is associated with a progressive, rapid increase in the level of triglycerides in the liver. The latter effect is related to either: .1) the elevated FFA concentration in the plasma and saturation of the normal mechanism for handling FFA by the liver, 2) liver damage from the experimental procedure in which the normal mechanism for handling FFA by the liver was compromised, 3) a direct or indirect effect of norepinephrine on the liver, or 4) a combination of any of the possibilities noted above. That the fatty liver was not caused by a direct effect of norepinephrine on liver metabolism is demonstrated by the portal vein infusion experiments in which norepinephrine failed to affect liver triglycerides except when plasma FFA was also affected. The possibility that the vasomotor effects of norepinephrine on hepatic circulation may have played a role in the development of the fatty liver cannot be ruled out by these experiments. That the experimental procedure, per se, independent of the norepinephrine effect, may have significantly damaged the liver seems unlikely, since no histopathological changes were noted in the livers of control animals and because of the highly significant differences in liver triglyceride observed between control and experimental animals. However, the possibility that the experimental procedure may have, in some unknown manner, restricted the normal capacity of the liver to handle FFA cannot be excluded. The study of the fatty acid composition of the newly deposited triglycerides helps establish that they were not synthesized by the liver de novo, since the linoleic acid content increased in proportion to the over-all increase in triglyceride fatty acids (25) . It has been shown that linoleic acid is not synthesized by mammalian liver (26) and rats, in particular, can be made deficient in linoleic acid (27) . The fact that the proportion of linoleic acid in the hepatic triglycerides remains the same despite a large increase in the total hepatic triglycerides does not prove that all of the fatty acids are derived from the periphery under the influence of norepinephrine, but does prove that the fraction of fatty acids derived from the periphery probably remains the same under the influence of the hormone as in control conditions. Furthermore, the pattern of the plasma FFA during the infusion of norepinephrine was altered so as to become almost identical with the pattern of fatty acids in the adipose tissue and strikingly similar to the fatty acid pattern of the newly formed hepatic triglycerides. These results seem to justify the hypothesis that the most probable sequence of events is the following: mobilization of fatty acids from adipose tissue by norepinephrine, transport to the liver, and incorporation into, liver triglycerides.
It has been established that an intact adrenal gland is essential for the production of certain kinds of fatty liver. This is true for the fatty liver due to phosphorus poisoning (1), prolonged fasting (2), exposure to cold (2), treatment with ethionine (3), and treatment with epinephrine (4). Recently it was shown directly that the ability of the animal to mobilize fatty acids from adipose tissue in response to epinephrine stimulation likewise depends upon the adrenal gland (28, 29) and possibly the pituitary gland (30) as well. It was suggested that the failure to induce fatty liver in the absence of the adrenal gland might be a reflection of this decreased ability of adipose tissue to respond in the animal with adrenocortical insufficiency. Also, it has been shown that adrenergic blocking agents inhibit the epinephrine-induced release of FFA from adipose tissue in vitro (31) , and that they also reduce the triglyceride deposition in normal rat livers induced by carbon tetrachloride, ethionine and ethanol (25) .
Putting the present studies into the context of available information concerning development of fatty liver, it is theoretically possible to propose two general categories, as indicated in Figure 8 and no rise in liver triglyceride. Studies of the fatty acid composition of the liver triglyceride, plasma FFA and adipose tissue triglyceride were consistent with the hypothesis that the newly formed liver triglyceride was synthesized from plasma FFA mobilized from adipose tissue. The role of plasma FFA in the development of fatty liver is discussed, and a scheme for the development of fatty liver under a variety of conditions is presented.
